ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Coronary Restenosis

  • The Effects of Bindarit in Preventing Stent Restenosis
  • XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
  • Oral Sirolimus for In-Stent Restenosis
  • Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
  • Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial
  • Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
  • Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
  • PIoglitazone for PrEvention of Restenosis in Diabetic Patients
  • Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
  • Serp-1 for the Treatment of Acute Coronary Syndrome
  • Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
  • Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
  • A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group